
Louis Navellier
Editor, Growth InvestorAn icon among growth stock investors
About Louis Navellier
Louis Navellier is one of Wall Street’s renowned growth investors. Providing investment advice to tens of thousands of investors for more than four decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager.
Over his investing career, Louis Navellier has established one of the most exceptional long-term track records of any financial newsletter editor in America, and he offers a wide range of simple yet powerful tools that can help all investors to significantly beat the market.
His popular Growth Investor advisory service, established in 1998, has outperformed the S&P 500 by a margin of 2-to-1.
Navellier continues to build on those stellar records, and while his methodology is rigorous and complex, his goal has been simple since the beginning: uncover the market’s best growth stocks and help investors beat the market with less risk. Today, he helps individual investors across the nation and across the globe achieve their financial dreams through his unique newsletter services.
The New York Times called Mr. Navellier “an icon among growth stock investors,” and the media frequently turns to Louis for his expert opinion. He appears regularly on CNBC and Fox Business News and is frequently quoted by MarketWatch, Bloomberg and The Wall Street Journal.
Navellier is an accomplished Wall Street insider as well. He and his team of professional analysts and staff manage nearly $1 billion in high-net worth funds and institutional accounts through his management company, Navellier & Associates.
Louis Navellier also has a YouTube channel, Navellier Market Buzz, where he posts regular video updates discussing the stock market. He is the author of the bestselling books, The Little Book That Makes You Rich and The Sacred Truths of Investing.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
Premium Services
Louis Navellier’s Growth Investor provides an expert’s take on the latest market trends and opportunities. Then Louis shares his picks of High-Growth Investments and Elite Dividend Payers — complete with volatility ratings and buy-below prices.
-
Stocks (Mid- to Large-Cap)
-
Conservative
-
Monthly trades
Already a member? Login here
If you want growth, you’ve got to look at smaller up-and-comers that aren’t as well-known... yet. Louis Navellier’s Breakthrough Stocks lets you participate in high-quality small-caps — according to your personal risk tolerance.
-
Stocks (Small to Mid-Cap)
-
Moderate to Aggressive
-
Monthly trades
Already a member? Login here
Accelerated Profits uses Louis Navellier’s proprietary stock-rating system to identify High Velocity and Ultimate Growth Trades. By combining the “one-two punch” of strong momentum and fundamentals with a more frequent trading schedule, you get significant returns... in a fraction of the time.
-
Stocks (Large-Cap)
-
Aggressive
-
Weekly trades
Already a member? Login here
Louis Navellier’s Platinum Growth combines the top-notch investing strategies of Growth Investor and Breakthrough Stocks with the faster pace of Accelerated Profits — all in a powerful new way that could improve your results 10-fold or better.
-
Stocks
-
Conservative to Aggressive
-
Weekly and monthly trades
Already a member? Login here
Recent Articles
5 Durable Goods Stocks in Need of Repair
The boom times are over. With consumer spending low, people are cutting back, which means durable goods stocks are feeling the pinch at the register.
4 Homebuilders With Shaky Foundations
Thanks to a glut of supply and falling home prices, homebuilders are struggling. Stocks Toll Brothers, Pulte and MDC should be sold ASAP.
7 Oil Companies Running on Fumes
There has been a lot of volatility in the crude oil and energy sectors recently. These seven oil companies are among the losers.
8 Superb Semiconductor Stocks to Buy
Semiconductor components are crucial to the technology we use every day. While some stocks continue to face headwinds, these 10 are thriving.
7 Pharma Stocks to Sell, STAT
Pharmaceutical stocks are theoretically recession-proof. Still, not all pharma companies are equal. Here are seven clear losers to toss.
10 Semiconductor Stocks Not Living Up to Expectations
Some semiconductor stocks are thriving, but some continue to face headwinds. These ten are not living up to expectations.
A Pair of Potential Earnings Casualties
Even though there are a lot of reasons to be optimistic about this earnings season, JPMorgan (JPM) and Hasbro (HAS) are heading for trouble.
3 Winners to Expect This Earnings Season
Earnings season has begun -- and these three highly-rated stocks are expected to hit it out of the park.
10 Big Pharma Stocks to Buy
Pharmaceutical stocks and drugmakers are theoretically recession-proof businesses. Still, not all pharma companies are created equal. Here are 10 clear winners
10 Revved-Up Oil Companies to Buy
There has been a lot of volatility in the crude oil and energy sectors recently, but it appears that the winners are now separating themselves from the losers.